2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure …
JW McEvoy, CP McCarthy, RM Bruno… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Treatment of hypertension: a review
Importance Hypertension, defined as persistent systolic blood pressure (SBP) at least 130
mm Hg or diastolic BP (DBP) at least 80 mm Hg, affects approximately 116 million adults in …
mm Hg or diastolic BP (DBP) at least 80 mm Hg, affects approximately 116 million adults in …
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Diretrizes brasileiras de hipertensão arterial–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
A HA tem alta prevalência e é um dos principais fatores de risco para as DCV e renais,
apresentando determinantes genéticos, ambientais e sociais combinados. Mostra-se de …
apresentando determinantes genéticos, ambientais e sociais combinados. Mostra-se de …
Brazilian guidelines of hypertension–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
SciELO - Brasil - Diretrizes Brasileiras de Hipertensão Arterial – 2020 Diretrizes Brasileiras de
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
The global epidemiology of hypertension
Hypertension is the leading cause of cardiovascular disease and premature death
worldwide. Owing to the widespread use of antihypertensive medications, global mean …
worldwide. Owing to the widespread use of antihypertensive medications, global mean …
The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)
S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …
Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk …
Objective To determine the relative efficacy of structured named diet and health behaviour
programmes (dietary programmes) for prevention of mortality and major cardiovascular …
programmes (dietary programmes) for prevention of mortality and major cardiovascular …
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart …
DK Arnett, RS Blumenthal, MA Albert… - Journal of the American …, 2019 - jacc.org
Although there has been substantial improvement in atherosclerotic cardiovascular disease
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force …
DK Arnett, RS Blumenthal, MA Albert… - Journal of the American …, 2019 - jacc.org
Although there has been substantial improvement in atherosclerotic cardiovascular disease
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …